Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability

Display Omitted

Gespeichert in:

Autor*in:	Romero, Gregori B. [verfasserIn] Arntjen, Anja Keck, Cornelia M. Müller, Rainer H.

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2016

Schlagwörter:	Nanoparticles Amorphous Nanocrystals Dermal Nanosuspension Cyclosporin A

Umfang:	8

Übergeordnetes Werk:	Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.]
Übergeordnetes Werk:	volume:498 ; year:2016 ; number:1 ; day:10 ; month:02 ; pages:217-224 ; extent:8

Links:	Volltext

DOI / URN:	10.1016/j.ijpharm.2015.12.019

Katalog-ID:	ELV029805481

Internformat


LEADER	01000caa a22002652 4500
001	ELV029805481
003	DE-627
005	20230623202711.0
007	cr uuu---uuuuu
008	180603s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.ijpharm.2015.12.019 \|2 doi
028	5	2	\|a GBVA2016013000013.pica
035			\|a (DE-627)ELV029805481
035			\|a (ELSEVIER)S0378-5173(15)30420-8
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0		\|a 610
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 610 \|q VZ
084			\|a 44.61 \|2 bkl
100	1		\|a Romero, Gregori B. \|e verfasserin \|4 aut
245	1	0	\|a Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
264		1	\|c 2016
300			\|a 8
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a Display Omitted
650		7	\|a Nanoparticles \|2 Elsevier
650		7	\|a Amorphous \|2 Elsevier
650		7	\|a Nanocrystals \|2 Elsevier
650		7	\|a Dermal \|2 Elsevier
650		7	\|a Nanosuspension \|2 Elsevier
650		7	\|a Cyclosporin A \|2 Elsevier
700	1		\|a Arntjen, Anja \|4 oth
700	1		\|a Keck, Cornelia M. \|4 oth
700	1		\|a Müller, Rainer H. \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier \|a Nigolian, H. ELSEVIER \|t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides \|d 2022 \|g New York, NY [u.a.] \|w (DE-627)ELV008932840
773	1	8	\|g volume:498 \|g year:2016 \|g number:1 \|g day:10 \|g month:02 \|g pages:217-224 \|g extent:8
856	4	0	\|u https://doi.org/10.1016/j.ijpharm.2015.12.019 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
936	b	k	\|a 44.61 \|j Innere Medizin \|q VZ
951			\|a AR
952			\|d 498 \|j 2016 \|e 1 \|b 10 \|c 0210 \|h 217-224 \|g 8
953			\|2 045F \|a 610

Indexfelder

author_variant	g b r gb gbr
matchkey_str	romerogregoribarntjenanjakeckcorneliamml:2016----:mrhuccoprnnnprilsoehnedr
hierarchy_sort_str	2016
bklnumber	44.61
publishDate	2016
allfields	10.1016/j.ijpharm.2015.12.019 doi GBVA2016013000013.pica (DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Romero, Gregori B. verfasserin aut Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier Arntjen, Anja oth Keck, Cornelia M. oth Müller, Rainer H. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8 https://doi.org/10.1016/j.ijpharm.2015.12.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 498 2016 1 10 0210 217-224 8 045F 610
spelling	10.1016/j.ijpharm.2015.12.019 doi GBVA2016013000013.pica (DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Romero, Gregori B. verfasserin aut Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier Arntjen, Anja oth Keck, Cornelia M. oth Müller, Rainer H. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8 https://doi.org/10.1016/j.ijpharm.2015.12.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 498 2016 1 10 0210 217-224 8 045F 610
allfields_unstemmed	10.1016/j.ijpharm.2015.12.019 doi GBVA2016013000013.pica (DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Romero, Gregori B. verfasserin aut Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier Arntjen, Anja oth Keck, Cornelia M. oth Müller, Rainer H. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8 https://doi.org/10.1016/j.ijpharm.2015.12.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 498 2016 1 10 0210 217-224 8 045F 610
allfieldsGer	10.1016/j.ijpharm.2015.12.019 doi GBVA2016013000013.pica (DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Romero, Gregori B. verfasserin aut Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier Arntjen, Anja oth Keck, Cornelia M. oth Müller, Rainer H. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8 https://doi.org/10.1016/j.ijpharm.2015.12.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 498 2016 1 10 0210 217-224 8 045F 610
allfieldsSound	10.1016/j.ijpharm.2015.12.019 doi GBVA2016013000013.pica (DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Romero, Gregori B. verfasserin aut Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier Arntjen, Anja oth Keck, Cornelia M. oth Müller, Rainer H. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8 https://doi.org/10.1016/j.ijpharm.2015.12.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 498 2016 1 10 0210 217-224 8 045F 610
language	English
source	Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8
sourceStr	Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:498 year:2016 number:1 day:10 month:02 pages:217-224 extent:8
format_phy_str_mv	Article
bklname	Innere Medizin
institution	findex.gbv.de
topic_facet	Nanoparticles Amorphous Nanocrystals Dermal Nanosuspension Cyclosporin A
dewey-raw	610
isfreeaccess_bool	false
container_title	Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides
authorswithroles_txt_mv	Romero, Gregori B. @@aut@@ Arntjen, Anja @@oth@@ Keck, Cornelia M. @@oth@@ Müller, Rainer H. @@oth@@
publishDateDaySort_date	2016-01-10T00:00:00Z
hierarchy_top_id	ELV008932840
dewey-sort	3610
id	ELV029805481
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029805481</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623202711.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2015.12.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016013000013.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029805481</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(15)30420-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Romero, Gregori B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Amorphous</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanocrystals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dermal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanosuspension</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cyclosporin A</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arntjen, Anja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Keck, Cornelia M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Rainer H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:498</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">day:10</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:217-224</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2015.12.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">498</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="b">10</subfield><subfield code="c">0210</subfield><subfield code="h">217-224</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Romero, Gregori B.
spellingShingle	Romero, Gregori B. ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
authorStr	Romero, Gregori B.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV008932840
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 610 DE-600 610 VZ 44.61 bkl Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A Elsevier
topic	ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A
topic_unstemmed	ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A
topic_browse	ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Amorphous Elsevier Nanocrystals Elsevier Dermal Elsevier Nanosuspension Elsevier Cyclosporin A
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	a a aa c m k cm cmk r h m rh rhm
hierarchy_parent_title	Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides
hierarchy_parent_id	ELV008932840
dewey-tens	610 - Medicine & health
hierarchy_top_title	Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV008932840
title	Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
ctrlnum	(DE-627)ELV029805481 (ELSEVIER)S0378-5173(15)30420-8
title_full	Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
author_sort	Romero, Gregori B.
journal	Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides
journalStr	Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2016
contenttype_str_mv	zzz
container_start_page	217
author_browse	Romero, Gregori B.
container_volume	498
physical	8
class	610 610 DE-600 610 VZ 44.61 bkl
format_se	Elektronische Aufsätze
author-letter	Romero, Gregori B.
doi_str_mv	10.1016/j.ijpharm.2015.12.019
dewey-full	610
title_sort	amorphous cyclosporin a nanoparticles for enhanced dermal bioavailability
title_auth	Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
abstract	Display Omitted
abstractGer	Display Omitted
abstract_unstemmed	Display Omitted
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U
container_issue	1
title_short	Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability
url	https://doi.org/10.1016/j.ijpharm.2015.12.019
remote_bool	true
author2	Arntjen, Anja Keck, Cornelia M. Müller, Rainer H.
author2Str	Arntjen, Anja Keck, Cornelia M. Müller, Rainer H.
ppnlink	ELV008932840
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth
doi_str	10.1016/j.ijpharm.2015.12.019
up_date	2024-07-06T22:25:29.149Z
_version_	1803870251673190400
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029805481</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623202711.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2015.12.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016013000013.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029805481</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(15)30420-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Romero, Gregori B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Amorphous</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanocrystals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dermal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanosuspension</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cyclosporin A</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arntjen, Anja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Keck, Cornelia M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Rainer H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:498</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">day:10</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:217-224</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2015.12.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">498</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="b">10</subfield><subfield code="c">0210</subfield><subfield code="h">217-224</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.399646

Nicht das Richtige dabei?

Schreiben Sie uns!

Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?